After the Stiko booster recommendation for people over 60 years of age, World Medical Association chairman Frank Ulrich Montgomery is now also in favor of a booster for younger people.
Berlin – The Corona autumn and especially the winter are imminent, and discussions about possible pandemic measures have long since flared up.
The fact that the Standing Vaccination Commission now recommends the second booster for everyone over the age of 60 is a good thing, according to World Medical Association Chairman Frank Ulrich Montgomery.
But now the booster should also be recommended for younger people, according to Montgomery.
Corona: World Medical Association boss Montgomery for booster recommendation also for under 60-year-olds
"Much younger people should also have access to the second booster vaccination, for example if they come into contact with many people professionally and therefore have a higher risk of infection," Montgomery told the
editorial network Germany
(Monday).
“The fact that there is a legal possibility to be vaccinated is not enough for many.
The Stiko should take that into account when making their decisions.” In addition, many doctors and hospitals would only vaccinate if the Stiko had made a positive decision.
Corona boosters for younger people too?
Stiko recommends second booster shot for people over 60
Since last week, Stiko has been recommending the second corona booster vaccination for people aged 60 and over.
The condition for the refresher from this age is usually that the first booster vaccination or the last corona infection was at least six months ago.
The committee had previously only recommended the second booster to people over the age of 70, people in care facilities, people with immunodeficiency and an increased risk of severe Covid 19 courses from the age of five and employees in medical facilities and care facilities.
With regard to the corona virus, the epidemiologist Klaus Stöhr looks to autumn and especially to the Oktoberfest.
In an interview, he reveals his forecast for the coming months.
Meanwhile, 280,000 packages of the corona drug Paxlovid are threatening to expire in 2023.
Karl Lauterbach is now promoting more and easier administration - and is reaping headwind for it.